BKD:NYE-Brookdale Senior Living Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 6.60

Change

0.00 (0.00)%

Market Cap

USD 1.24B

Volume

1.27M

Avg Analyst Target

USD 10.00 (+51.52%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates through five segments: Independent Living, Assisted Living and Memory Care, Continuing Care Retirement Communities (CCRCs), Health Care Services, and Management Services. The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily life to mid-acuity and frail elderly residents. This segment also operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that offer various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and health needs. The Health Care Services segment provides home health, hospice, and outpatient therapy services. The Management Services segment operates communities under the management agreements. As of December 31, 2020, the company owned 350 communities, leased 301 communities, managed 72 communities on behalf of third parties, and 3 communities for which it has equity interest. Brookdale Senior Living Inc. is headquartered in Brentwood, Tennessee. Address: 111 Westwood Place, Brentwood, TN, United States, 37027

Company Website : http://www.brookdale.com

Address : 111 Westwood Place, Brentwood, TN, United States, 37027

Employees : 31,500

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 1.82

52 Week High : 8.95

Short Ratio : 3.76

52 Week Low : 2.55

Shorted Shares : 10,555,604

200 Day Moving Average : 7.12

Shorted Shares Previous Month : 8,804,890

50 Day Moving Average : 6.60

Shares Held By Insiders : 1.05%

Short Percentage : 6.00%

Shares Held by Institutions : 92.98999999999999%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-17 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Healthcare Inc

N/A

 USD79.04B 16.95 9.54
FMS Fresenius Medical Care AG & Co..

N/A

 USD20.78B 17.95 8.96
DVA DaVita Inc

N/A

 USD11.75B 15.09 9.67
UHS Universal Health Services Inc

N/A

 USD11.06B 10.53 7.08
OSH Oak Street Health Inc

N/A

 USD9.92B N/A N/A
AGL agilon health inc

N/A

 USD9.37B N/A N/A
THC Tenet Healthcare Corporation

N/A

 USD6.80B 15.78 6.95
CHE Chemed Corporation

N/A

 USD6.77B 23.08 14.63
EHC Encompass Health Corporation

N/A

 USD6.73B 17.63 9.65
SEM Select Medical Holdings Corpor..

N/A

 USD4.50B 10.50 7.70

ETFs Containing BKD

Symbol Name Weight Mer Price(Change) Market Cap
PRFZ Invesco FTSE RAFI US 1500.. 0.00 % 0.39 %

N/A

 USD2.01B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 48.98% 79% C+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.98% 79% C+ 87% B+
Trailing 12 Months  
Capital Gain 126.80% 89% B+ 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 126.80% 89% B+ 92% A-
Trailing 5 Years  
Capital Gain -57.36% 20% F 7% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -57.36% 20% F 5% F
Average Annual (5 Year Horizon)  
Capital Gain -3.70% 11% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.70% 11% F 7% F
Risk Return Profile  
Volatility (Standard Deviation) 66.30% 26% F 12% F
Risk Adjusted Return -5.58% 16% F 10% F
Market Capitalization 1.24B 35% F 53% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 800.22 6% F 1% F
Price/Book Ratio 2.14 79% C+ 46% F
Price / Cash Flow Ratio 6.01 35% F 60% D-
EV/EBITDA 31.58 11% F 13% F
Management Effectiveness  
Return on Equity -46.41% 32% F 11% F
Return on Invested Capital 0.04% 30% F 30% F
Return on Assets -1.21% 24% F 14% F
Debt to Equity Ratio 479.25% 33% F 6% F
Technical Ratios  
Short Ratio 3.76 48% F 29% F
Short Percent 7.35% 17% F 32% F
Beta 1.82 26% F 15% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector